InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 804,525
- Total 13F shares
- 804,163
- Share change
- +777,383
- Total reported value
- $334,349
- Price per share
- $0.42
- Number of holders
- 13
- Value change
- +$315,907
- Number of buys
- 9
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 457637601:
Top shareholders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
3.3%
|
26,589
|
$18,346 | — | 30 Sep 2023 | |
| Bruce Colwill |
3/4/5
|
CFO |
—
class O/S missing
|
11,515
|
$10,294 | — | 24 Jan 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.01%
|
85
|
$76 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
69
|
$48 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
61
|
$40 | — | 30 Sep 2023 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
21
|
$14 | — | 30 Sep 2023 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
20
|
$13 | — | 30 Sep 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
19
|
$13 | — | 30 Sep 2023 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
2
|
$1 | — | 30 Sep 2023 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2023 | |
| Mr. Jonathan Tegge |
3/4/5
|
Interim CFO |
—
class O/S missing
|
31,400
|
— | — | 23 Dec 2023 | |
| Catherine Sazdanoff |
3/4/5
|
Director |
—
class O/S missing
|
29,091
|
— | — | 29 Dec 2021 | |
| Adam D. Cutler |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Mr. William J. Garner |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Ms. Sarah Li |
3/4/5
|
VP Accounting & Controller |
—
class O/S missing
|
4,002
|
— | — | 16 Dec 2022 |
Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q4 2023
As of 31 Dec 2023,
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
804,163 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, Qube Research & Technologies Ltd, BANK OF AMERICA CORP /DE/, Advisory Services Network, LLC, OSAIC HOLDINGS, INC., and AllSquare Wealth Management LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
8
Q4 2023 holders
13
Holder diff
5
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.